AEON Biopharma (AEON) Enterprise Value (2021 - 2026)
AEON Biopharma (AEON) posted Enterprise Value of -$3.0 million for Q4 2025, up 49.38% sequentially from -$5.9 million in Q3 2025, and down 22976.92% YoY from N/an in Q4 2024.
AEON Biopharma (AEON) Enterprise Value (2021 - 2026) Analysis & Trends
AEON Biopharma has reported Enterprise Value for 5 years, with the latest figure at -$3.0 million in Q4 2025.
- Quarterly Enterprise Value fell 22976.92% year-over-year to -$3.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$3.0 million (down 22976.92% YoY) and the FY2025 annual result came in at -$3.0 million, down 22976.92% from the prior year.
- Enterprise Value climbed to -$3.0 million in Q4 2025 per AEON's latest filing, from -$5.9 million in the prior quarter.
- Over five years, Enterprise Value peaked at $128.2 million in Q4 2022 and troughed at -$16.2 million in Q3 2023.
- A 5-year average of $3.4 million and a median of -$826197.5 in 2021 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2022 and 2023: Enterprise Value soared 25874.01% in 2022, then sank 58176.59% in 2023.
- Over 5 years, Enterprise Value stood at -$497412.0 in 2021, then jumped by 25874.01% to $128.2 million in 2022, then sank by 104.02% to -$5.2 million in 2023, then jumped by 99.75% to -$13000.0 in 2024, then sank by 22976.92% to -$3.0 million in 2025.
- According to Business Quant data, Enterprise Value over the past three periods registered -$3.0 million, -$5.9 million, and -$8.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.90 Bn | 131.05 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 86.10 Bn | 78.11 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 65.56 Bn | 60.37 Bn | 1.37 Bn | -5.18 Bn |
| 4 | Moderna | 55.82 Bn | 50.68 Bn | 52.00 Mn | -5.14 Bn |
| 5 | BeOne Medicines | 42.14 Bn | 37.04 Bn | 1.53 Bn | -5.10 Bn |
| 6 | Alnylam Pharmaceuticals | 31.67 Bn | 28.36 Bn | 992.69 Mn | -3.31 Bn |
| 7 | BioNTech SE | 27.74 Bn | 9.35 Bn | 668.28 Mn | -18.39 Bn |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | -1.16 Bn |
| 9 | Royalty Pharma | 27.38 Bn | 26.54 Bn | - | 2.12 Bn |
| 10 | AEON Biopharma | 9.56 Mn | 6.13 Mn | - | -3.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.43 Mn |
| Dec 31, 2025 | -3.00 Mn |
| Sep 30, 2025 | -5.93 Mn |
| Jun 30, 2025 | -8.40 Mn |
| Mar 31, 2025 | -10.45 Mn |
| Dec 31, 2024 | -13,000.00 |
| Sep 30, 2024 | -537,000.00 |
| Jun 30, 2024 | -3.40 Mn |
| Mar 31, 2024 | -1.56 Mn |
| Dec 31, 2023 | -5.16 Mn |
| Sep 30, 2023 | -16.18 Mn |
| Jun 30, 2023 | -441,377.00 |
| Mar 31, 2023 | -457,085.00 |
| Dec 31, 2022 | 128.20 Mn |
| Sep 30, 2022 | -27,759.00 |
| Jun 30, 2022 | -7,758.00 |
| Mar 31, 2022 | -166,243.00 |
| Dec 31, 2021 | -497,412.00 |
| Sep 30, 2021 | -663,540.00 |
| Jun 30, 2021 | -988,855.00 |